Buy Dutas

Dutas

What is Dutas?

Dutas is a prescription medication that contains the active ingredient dutasteride. It belongs to the Men’s Health therapeutic class and is formulated as a 0.5 mg pill. In Hong Kong, Dutas is regulated by the Pharmacy and Poisons Board and is available only with a physician’s prescription. Dutasteride is also marketed under other brand names worldwide, but Dutas refers specifically to the 0.5 mg tablet formulation.

How Dutas Works in the Body

Dutasteride is a dual 5-alpha-reductase inhibitor. It blocks both type 1 and type 2 isoenzymes that convert testosterone into dihydrotestosterone (DHT), a hormone that drives prostate tissue growth and contributes to male pattern hair loss. By lowering DHT levels, Dutas reduces the stimulus for prostate enlargement and can improve related urinary symptoms. The drug reaches peak plasma concentrations within 2-3 hours after oral ingestion, and its biological effects persist because it has a long half-life of approximately 5 weeks, allowing steady suppression of DHT with once-daily dosing.

Conditions Treated by Dutas

• Benign Prostatic Hyperplasia (BPH) - Dutas is FDA- and EMA-approved for the treatment of symptomatic BPH in adult men. It improves urinary flow and decreases the risk of acute urinary retention.
• Adjunct to Finasteride for BPH - In some clinical guidelines, dutasteride is recommended as an alternative to finasteride when a stronger DHT reduction is desired.

These indications are recognized by Hong Kong health authorities, and Dutas is prescribed for men with an enlarged prostate who experience urinary difficulty, frequency, or urgency.

Off-Label and Investigational Applications

• Male Pattern Alopecia (Androgenic Hair Loss) - Dutasteride has been studied in clinical trials for hair regrowth in men, showing reductions in hair shedding and increases in hair density. However, it is not approved for this use in Hong Kong. Off-label use for hair loss should be undertaken only under close supervision of a qualified dermatologist.
• Prostate Cancer Prevention - Early-phase research explored dutasteride’s role in reducing the incidence of low-grade prostate cancer, but concerns about potential promotion of high-grade disease have limited its adoption. This application remains investigational and is not endorsed by regulatory agencies.

Disclaimer: Off-label use requires medical supervision and an individualized risk assessment.

Who Should Not Use Dutas?

• Absolute Contraindications

• Known hypersensitivity to dutasteride or any tablet excipients.

• Women (including pregnant or breastfeeding women) - dutasteride can cause fetal abnormalities.

• Relative Contraindications

• Severe hepatic impairment (Child-Pugh class C) - reduced clearance may increase exposure.

• Patients with a history of breast cancer or unexplained breast tenderness.

• Special Populations

• Elderly Men: No dosage adjustment is required solely on the basis of age, but clinicians should assess liver function.

• Renal Impairment: No specific dose change is recommended, but monitoring is prudent when creatinine clearance is markedly reduced.

If any of these conditions apply, patients should discuss alternative therapies with their healthcare provider.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Decreased libido - reported in a minority of users and often improves with continued treatment.
• Erectile dysfunction - may appear early in therapy; persists in a small proportion of patients.
• Ejaculatory disorders - reduced volume or delayed ejaculation are occasionally noted.
• Breast tenderness or enlargement - mild cases are self-limiting; persistent swelling warrants evaluation.

These effects are generally mild and reversible upon discontinuation.

Serious Adverse Events

• Breast Cancer Risk - long-term exposure has been linked to a slightly increased incidence of male breast cancer; regular breast examinations are advised.
• High-Grade Prostate Cancer - some studies suggest an elevated risk of aggressive prostate cancer; periodic PSA monitoring is essential.
• Severe Allergic Reactions - urticaria, angioedema, or anaphylaxis require immediate medical attention.

Drug Interactions

• CYP3A4 Inhibitors (e.g., ketoconazole, itraconazole) - may raise dutasteride plasma levels; dose adjustment is not routinely recommended but clinicians should monitor for heightened side effects.
• CYP3A4 Inducers (e.g., rifampin, carbamazepine) - can lower dutasteride concentrations, potentially reducing efficacy.
• Warfarin - case reports indicate possible increased INR; periodic coagulation testing is advisable when the drugs are co-prescribed.

Food and Lifestyle Interactions

• Dutas can be taken with or without food; meals do not significantly alter absorption.
• No known interactions with alcohol, but excessive intake may exacerbate urinary symptoms.
• Patients should avoid operating heavy machinery if they experience dizziness or visual disturbances.

Patients should inform their healthcare provider of all medicines, supplements, and herbal products before starting Dutas.

How to Take Dutas

• Standard Dosing: One 0.5 mg tablet taken orally once daily. The tablet may be swallowed whole with water; it does not need to be split or crushed.
• Special Populations:
• Hepatic Impairment: No routine dose reduction, but clinicians may consider a lower dose if liver function is markedly compromised.
• Elderly: Continue the standard dose; monitor for side effects.
• Missed Dose: If a dose is forgotten, take it as soon as remembered unless it is near the time of the next scheduled dose. Do not double the dose.
• Overdose: Symptoms may include nausea, vomiting, dizziness, or low blood pressure. Seek emergency medical care; supportive measures are the primary treatment.
• Discontinuation: No tapering is required. If therapy is stopped, DHT levels will gradually rise back to baseline over several weeks.

Monitoring and Follow-Up

• Prostate-Specific Antigen (PSA) Testing: Baseline PSA should be measured before initiating Dutas, with follow-up every 6-12 months to assess treatment response and screen for prostate cancer.
• Liver Function Tests: Periodic assessment is advisable for patients with pre-existing hepatic disease.
• Clinical Review: Patients should report persistent sexual side effects, breast changes, or signs of allergic reaction promptly.

Storage and Handling

• Store Dutas tablets at room temperature (15 °C-30 °C), away from excess moisture and direct sunlight.
• Keep the container tightly closed and out of reach of children.
• Do not use the medication after the printed expiration date.

Medication-Specific Glossary

5-Alpha-Reductase

An enzyme that converts testosterone into the more potent androgen dihydrotestosterone (DHT).

Dihydrotestosterone (DHT)

A hormone that stimulates prostate growth and contributes to male pattern hair loss.

Prostate-Specific Antigen (PSA)

A protein produced by prostate cells; elevated levels can indicate BPH progression or prostate cancer.

Hyperplasia

An increase in the number of cells within an organ, leading to enlargement; in BPH, this occurs in the prostate gland.

Androgen

A class of hormones, including testosterone and DHT, that regulate male sexual development and reproductive function.

Medical Disclaimer

This article provides educational information about Dutas and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.